In conclusion, this study (i) identifies ERα36 as a relevant classifier whose expression level should be taken into account for breast tumors clinical characterization and [ER+] tumor treatment orientation, (ii) confirms ex vivo previous in vitro data connecting high ERα36 expression to enhanced expression of migration/invasion markers and (iii) generates a novel approach for the rapid, cheap and relevant evaluation of any candidate gene expression as a predictor of a complex biological process. Here, ESR1 is linked to breast neoplasm.